Clik here to view.
Researchers Reveal Racial Disparities in Access to Remdesivir for Patients...
Results from an observational study revealed that patients with cancer who also were infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were treated with unproven,...
View ArticleClik here to view.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should...
The COVID-19 pandemic prompted changes to standard practices for cancer clinical trials, and thought leaders have recommended continuing — and improving upon — those new practices. These...
View ArticleClik here to view.
Drug Shortages Threaten Childhood Cancer Treatment
Childhood cancers have seen remarkable improvements in prognosis over the past few decades, with survival rates in countries such as the US at around 85%.1 Although prognosis varies widely between the...
View ArticleClik here to view.
FDA Calls for Patient Registries to Track Robotically Treated Cancers
The US Food and Drug Administration’s (FDA’s) recent warning about robotic surgery for treating or preventing cancer came as a surprise to some physicians, given the technology’s pervasive reach and...
View ArticleClik here to view.
Chemotherapy-Stimulated Immune Response: An Open Debate
A recent review suggested that chemotherapy may prime cancer to respond to checkpoint inhibition.1 According to the review, which was published in the Annals of Oncology earlier this year, this may...
View Article